BeStock  
Stocks › Biotechnology › SLBT

SL Science SLBT

US equityMarket cap rank #3363Biotechnology
$1.51 −$0.01 (-0.66%)
Market closed · Oct 8, 7:00 am ET · Last extended-hours $1.50 -0.66%
Open$1.51
Prev close$1.52
Day range$1.50 – $1.57
Volume68.4K
Market cap$846.75M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readStrong downtrend

1 bullish · 6 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-13.7%BearishTrading below the 20-day average of $1.75
Price vs 50-day average-36.0%BearishTrading below the 50-day average of $2.36
Price vs 200-day average-78.0%BearishTrading below the 200-day average of $6.87
50-day vs 200-day50d below 200dBearishThe 50-day average is below the 200-day average
RSI (14)32.9BearishMomentum leans negative
MACD (12,26,9)-0.28BullishMACD line is above its signal line
Bollinger band position18%BearishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$1.75-13.7%
50-day SMA$2.36-36.0%
200-day SMA$6.87-78.0%

Recent price levels

LevelPrice
20-day high$2.62
20-day low$1.42
60-day high$4.73
60-day low$1.42
Upper Bollinger band$2.13
Lower Bollinger band$1.37

The 50-day average is currently 65.7% below the 200-day average — consistent with a “death cross” (bearish) configuration.

30-day volatility120.3%
Average true range10.45% of price
Max drawdown (1y)-88.2%
Volume (10d vs 90d)0.18x

Discussion

No comments yet — be the first to weigh in on SLBT.

Leave a comment

Scroll to Top